Abstract
Management and successful use of vascular access are critical issues in pediatric patients affected by malignancies. Prolonged course of disease, complex and various treatment protocols require long-lasting vascular access providing adequate tools to administrate those therapies and to collect routine blood sampling without painful and repeated venipuncture. For these reasons, central venous catheters are currently an important component in pediatric onco-hematological care, with a direct influence on outcome. Indeed, there are peculiar issues (techniques of insertion, management, complications etc.) which must be well-known in order to improve the outcome and the quality of life of children with cancer.
Highlights
Cancer is a rare condition in children, it represents the second most common cause of death in patients older than 12 months [1,2]
(30% in 60’s to around 98% in 2020) [6] and Wilms tumor (20% to 93%) [7,8]. All those successes have been accomplished since the introduction of the concept of multidisciplinary treatment in pediatric onco-hematology: more intensive chemotherapy and radiotherapy regimens, possibility of stem cells/bone marrow transplantation, introduction of new therapies and different surgical approaches have been developed over the last decades, playing an important role in different treatment protocols and having a direct influence on the outcome
Patient’s requirements are the first and most important issue to consider for the choice of vascular access device (VAD), taking into account expected duration, type and previous history of onco-hematology treatment
Summary
Cancer is a rare condition in children, it represents the second most common cause of death in patients older than 12 months [1,2]. A more remarkable improvement has been reported for tumors like acute lymphoblastic leukemia (5% in early 50’s to 91% in 2020) [4,5], lymphomas (30% in 60’s to around 98% in 2020) [6] and Wilms tumor (20% to 93%) [7,8] All those successes have been accomplished since the introduction of the concept of multidisciplinary treatment in pediatric onco-hematology: more intensive chemotherapy and radiotherapy regimens, possibility of stem cells/bone marrow transplantation, introduction of new therapies (like immune and target therapy) and different surgical approaches have been developed over the last decades, playing an important role in different treatment protocols and having a direct influence on the outcome. The aim of this paper is the provide an updated review of the general recommendations for VADs management
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
